HR 4212
103th Congress
House
Taxation
Accounting
Biotechnology
Business losses
Capital gains tax
Commerce
Corporation taxes
Costs
Economics and Public Finance
Employee stock options
Finance and Financial Sector
Income tax
Indexing (Economic policy)
Labor and Employment
Profit
Research and development
Research and development tax credit
Restricted stock options
Science, Technology, Communications
Stocks
Biotechnology Stimulus Act of 1994
Introduced: April 14, 1994
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 21, 1994
Sponsor introductory remarks on measure. (CR H2590)
Apr 14, 1994
Referred to the House Committee on Ways and Means.
Apr 14, 1994
Introduced in House
Plain-English summary
Biotechnology Stimulus Act of 1994 - Amends the Internal Revenue Code with regard to the biotechnology research credit to: (1) establish an alternative credit calculation based on aggregate research expenses; and (2) make the credit permanent.
Establishes: (1) a biotechnology variable capital gains deduction; and (2) a capital gains exclusion for biotechnology startup business stock held for more than two years.
Provides for the indexing of certain capital assets for purposes of gain or loss determinations.
Expresses the sense of the Congress that accounting standards should not be changed to require that biotechnology businesses deduct the value of stock options from their profits.
What's happening now
Sponsor introductory remarks on measure. (CR H2590)
Committees of jurisdiction
1
Cosponsors
1